Otolaryngology Doctors in Rolling Meadows, IL Accepting Medicare
7 Otolaryngology doctors found. Showing 1 - 7
 Dr. Allan A Ho, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
Dr. Lon J Petchenik, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
Dr. Glenn J Schwartz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
Dr. George Smyrniotis, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
 Mrs. Marci Pugnale, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
Mrs. Maria Latev Wittkopf, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
Dr. Kirk R Clark, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5999 New Wilke Rd Bldg 1, Rolling Meadows, IL 60008 Phone: 847-259-2530 Fax: 847-259-4930 |
News Archive
MPA approves Renishaw study into chronic drug delivery system in Parkinson's patients
The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc's randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw's chronic drug delivery system, in Parkinson's patients.
New NIMH plan provides a framework for advancing mental health research
The National Institute of Mental Health has released its 2020 Strategic Plan for Research. The new plan provides a framework for advancing research priorities that support the institute's mission: To transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.
Discovery of pathway that reactivate myelin repair
UMDNJ researchers have identified a key pathway that could lead to new therapies to repair nerve cells' protective coating stripped away as a result of autoimmune diseases such as Multiple Sclerosis (MS). An article reporting their findings will appear in the May 13 online edition of the Journal of Neuroscience.
Protein kinase inhibitors could help treat immunodeficiency in HIV patients
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
› Verified 5 days ago
Internal Medicine
Family Medicine
Otolaryngology
Hematology & Oncology
Gastroenterology
Pain Medicine
Pediatrics
Emergency Medicine
Dermatology
Nephrology